Medical Condition News

RSS

Adult survivors of childhood cancer at risk for pituitary hormone deficiencies

Decades after undergoing cranial irradiation for childhood cancer, St. Jude Children's Research Hospital investigators found that adult survivors of pediatric cancer remain at risk for pituitary hormone deficiencies that may diminish their health and quality of life.

16 Feb 2015

R. Bryan Miller Symposium to spotlight special focus on rare disease research

The University of California, Davis Department of Chemistry will spotlight a special focus on rare disease research with this year's 15th annual R. Bryan Miller Symposium. Experts in rare diseases will gather at the UC Davis Conference Center March 5 for a conference highlighting the opportunities and challenges in applying cutting edge technologies and "precision medicine" to better treat conditions that together affect millions of people, especially children.

16 Feb 2015

Novartis receives priority review status from FDA for heart failure medicine LCZ696

Novartis announced today that the US Food and Drug Administration has granted priority review for LCZ696, an investigational medicine for the treatment of heart failure with reduced ejection fraction (HFrEF). The designation is intended to accelerate the review of therapies that offer a significant improvement in the safety or effectiveness of the treatment, prevention or diagnosis of a serious condition.

16 Feb 2015

Study shows in-flight blood transfusions improve outcomes in trauma victims

Air-lifted trauma victims who received blood transfusions in the helicopter before arriving at a trauma center had higher one-day survival rates and less chance of shock than air-lifted patients who did not receive blood transfusions until they arrived at the trauma unit, according to study findings published online in the Journal of the American College of Surgeons.

16 Feb 2015

Researchers develop novel strategy in fight against cancer

A team of researchers led by Associate Professor Caroline Lee from the Yong Loo Lin School of Medicine at the National University of Singapore, in collaboration with Associate Professor Song Jianxing of the Department of Biological Sciences at the NUS Faculty of Science, has developed a novel strategy in the fight against cancer.

15 Feb 2015

New technology can help identify patients at risk of second stroke

Risk of recurrent stroke is higher in patients who have low blood flow to the back of the brain, a six-year, multi-center trial has found, and the condition can be visualized using specialized software developed at the University of Illinois at Chicago that analyzes blood flow using standard MRI.

15 Feb 2015

Study finds link between type 2 diabetes and reduction of certain cognitive abilities

Type 2 diabetes is associated with worse performance on cognitive tests measuring abilities involved in the control of emotions, behaviours and thought, says a new study from the University of Waterloo.

15 Feb 2015

Researchers identify two cell-signaling molecules that appear critical to stalling cancer's spread

In what is believed to be the largest epigenetic analysis to date of cell-signaling molecules in early-stage melanoma, researchers at NYU Langone Medical Center and its Laura and Isaac Perlmutter Cancer Center have identified two tiny bits of non-coding genetic material in primary tumors that appear critical to stalling the cancer's spread -- and essentially setting the biological fate of the disease.

15 Feb 2015

New Penn Medicine study reveals how sleep deprivation increases intake of fat

Experts have warned for years that insufficient sleep can lead to weight gain. A new Penn Medicine study found that not only do we consume more food following a night of total sleep deprivation, but we also we consume more fat and less carbohydrates and a region of the brain known as the salience network is what may lead us to eat more fat.

15 Feb 2015

UT Southwestern researchers identify common signaling mechanism that controls immune system

UT Southwestern Medical Center researchers have identified a common signaling mechanism to produce interferon - one of the main proteins used to signal the immune system when the body needs to defend itself against a virus, tumor, or other diseases.

15 Feb 2015

A*STAR's GIS scientists develop new system that can predict treatment targets for cancer

In recent months, several national initiatives for personalized medicine have been announced, including the recently launched precision medicine initiative in the US, driven by rapid advances in genomic technologies and with the promise of cheaper and better healthcare. Significant challenges remain, however, in the management and analysis of genetic information and their integration with patient data.

15 Feb 2015

Young women report greater stress than men after heart attack

Young and middle-aged women experience more stress than their male counterparts, which could contribute to worse recovery from acute myocardial infarction (AMI), according to new findings by Yale School of Medicine researchers and their colleagues.

15 Feb 2015

$Eisai announces FDA approval of LENVIMA (lenvatinib) for treatment of RAI-refractory DTC$

Eisai announces FDA approval of LENVIMA (lenvatinib) for treatment of RAI-refractory DTC

Eisai Inc. announced today that the U.S. Food and Drug Administration approved the company's receptor tyrosine kinase inhibitor LENVIMA (lenvatinib) for the treatment of locally recurrent or metastatic, progressive, radioactive iodine-refractory differentiated thyroid cancer (RAI-R DTC).

13 Feb 2015

Declarative memory helps individuals with neurodevelopmental disorders compensate for dysfunction

Individuals with five neurodevelopmental disorders -- autism spectrum disorder, obsessive-compulsive disorder, Tourette syndrome, dyslexia, and Specific Language Impairment -- appear to compensate for dysfunction by relying on a single powerful and nimble system in the brain known as declarative memory.

13 Feb 2015

Biomedical use of gold nanotubes demonstrated in mouse model of human cancer

Scientists have shown that gold nanotubes have many applications in fighting cancer: internal nanoprobes for high-resolution imaging; drug delivery vehicles; and agents for destroying cancer cells.

13 Feb 2015

Camp Twinkletoes improves lives of children suffering from juvenile arthritis

Throughout NSW, there are more than 6,000 children suffering from the extreme pain and fatigue of juvenile arthritis. Usually thought of as an ‘older persons’ disease, arthritis in children is a very real condition, and in extreme cases can even result in death.

13 Feb 2015

Jazz Pharmaceuticals to present defibrotide results for hepatic VOD at BMT Tandem meetings

Jazz Pharmaceuticals plc announced today that researchers will present data on the use of defibrotide, an investigational medicine being studied in the United States (U.S.) for the treatment of hepatic veno-occlusive disease (VOD), a rare, potentially life-threatening, early complication in patients undergoing hematopoietic stem-cell transplantation (HSCT) therapy.

13 Feb 2015

Clinical trial proves ‘inside the artery’ therapy improves patient outcomes after stroke

"This clinical trial proves beyond any doubt that inside the artery therapy is the best possible treatment for patients suffering an acute ischemic stroke from a large artery occlusion," according to Donald Frei, MD, Neuro Interventional Surgeon at Swedish Medical Center and Radiology Imaging Associates in Englewood, CO.

13 Feb 2015

JDRF supports Janssen's DIA approach to combat type 1 diabetes

JDRF, the leading research and advocacy organization funding type 1 diabetes (T1D) research, announced today its alignment with an innovative scientific approach of Janssen Research & Development, LLC (Janssen) and the company's Disease Interception Accelerator (DIA) group, which will focus on transforming type 1 diabetes through its disease interception strategy.

13 Feb 2015

Thync electrical neurosignaling reduces brain's response to stress, shows study

Thync today announced results from a study published via bioRxiv that show electrical neurosignaling delivered by its consumer wearable device reduces the brain's response to stress in a chemical-free manner.

13 Feb 2015

Medical Condition News

Adult survivors of childhood cancer at risk for pituitary hormone deficiencies

R. Bryan Miller Symposium to spotlight special focus on rare disease research

Novartis receives priority review status from FDA for heart failure medicine LCZ696

Study shows in-flight blood transfusions improve outcomes in trauma victims

Researchers develop novel strategy in fight against cancer

New technology can help identify patients at risk of second stroke

Study finds link between type 2 diabetes and reduction of certain cognitive abilities

Researchers identify two cell-signaling molecules that appear critical to stalling cancer's spread

New Penn Medicine study reveals how sleep deprivation increases intake of fat

UT Southwestern researchers identify common signaling mechanism that controls immune system

A*STAR's GIS scientists develop new system that can predict treatment targets for cancer

Young women report greater stress than men after heart attack

Eisai announces FDA approval of LENVIMA (lenvatinib) for treatment of RAI-refractory DTC

Declarative memory helps individuals with neurodevelopmental disorders compensate for dysfunction

Biomedical use of gold nanotubes demonstrated in mouse model of human cancer

Camp Twinkletoes improves lives of children suffering from juvenile arthritis

Jazz Pharmaceuticals to present defibrotide results for hepatic VOD at BMT Tandem meetings

Clinical trial proves ‘inside the artery’ therapy improves patient outcomes after stroke

JDRF supports Janssen's DIA approach to combat type 1 diabetes

Thync electrical neurosignaling reduces brain's response to stress, shows study

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News